Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
Mwayi KachapilaAdesoji O AdemuyiwaBruce M BiccardDhruva N GhoshJames GlasbeyMark MonahanRachel MooreDion G MortonRaymond OppongRupert PearseTracy E Robertsnull nullnull nullnull nullPublished in: PloS one (2021)
Both the absence and presence of SARS-CoV-2, mouthwash is likely to be cost saving intervention for reducing pneumonia after abdominal surgery. However, the available evidence for the effectiveness of mouthwash was extrapolated from cardiac surgery; there is now an urgent need for a robust clinical trial on the intervention on non-cardiac surgery.
Keyphrases
- cardiac surgery
- randomized controlled trial
- sars cov
- south africa
- clinical trial
- end stage renal disease
- acute kidney injury
- patients undergoing
- chronic kidney disease
- systematic review
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- study protocol
- patient reported outcomes
- respiratory syndrome coronavirus
- intensive care unit
- respiratory failure
- community acquired pneumonia
- acute respiratory distress syndrome